Serum hepatic enzyme manifestations in patients with severe acute respiratory syndrome: Retrospective analysis

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 10, Issue 11

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

248

HTML

2962

Figures (1-2)

116

Tables (1-5)

113

Sum=3439

Jun 1, 2004 (publication date) through Apr 25, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Clinical Research

World J Gastroenterol. Jun 1, 2004; 10(11): 1652-1655
Published online Jun 1, 2004. doi: 10.3748/wjg.v10.i11.1652

Figure 1 Abnormal-liver-function outcomes at different days.

Figure 2 The distribution of of ribavirin treatment in 84 SARS patients.

Citation: Cui HJ, Tong XL, Li P, Hao YX, Chen XG, Li AG, Zhang ZY, Duan J, Zhen M, Zhang B, Hua CJ, Gong YW. Serum hepatic enzyme manifestations in patients with severe acute respiratory syndrome: Retrospective analysis. World J Gastroenterol 2004; 10(11): 1652-1655
URL: https://www.wjgnet.com/1007-9327/full/v10/i11/1652.htm
DOI: https://dx.doi.org/10.3748/wjg.v10.i11.1652